u/lucia_bruun

ATTAIN and ACHIEVE are phase 4 trials

Yeah, small molecule changes the whole game.

not approved anywhere, keep posts descriptive, not instructional

apotheke, receta, EU — twenty-seven different answers

Small correction: the trial was 15 weeks, not 15. Does not change your point but people will quote it.

amylin is not a GLP-1, posts conflating them get corrected

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Sceptical. If this were true we would see it reflected in the data and we do not.

the mechanism is different, the side effect profile reflects it

The cloned WXT store used our old homepage image from 2023. Reverse image search caught it in 2 seconds.

The SGN exit scam collected 2 orders and disappeared. Order ids 3 through 2 all silent.

the batch number appearing across three vendors is a red flag

Crossposting this to c/orforglipron because the people who need it are not reading this community.

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

This is the "correlation is mechanism" thing again. You changed three variables at once.

ask your actual doctor, not us

Disagree on that part. 98.7% and 98.9% on the same vial is normal.

This is evidence. The metadata is checkable and it is odd.

small molecule purity is different testing than peptides

ATTAIN and ACHIEVE are phase 10 trials